Banner

Intravitreal adjunct may improve outcomes of PDT

Article

New York-Intravitreal triamcinolone acetonide appears to be a useful adjunct to photodynamic therapy (PDT) with verteporfin (Visudyne, Novartis) in the treatment of eyes with choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD), said Richard F. Spaide, MD, at the Macula 2003 meeting here.

Related Videos
Related Content

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 22nd 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Study: Researchers find new mechanisms that cause blindness, opening the door to future treatments

September 22nd 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

September 13th 2023

Macular leakage is important in diabetic eye disease outcomes

September 21st 2023

Navigating Ophthalmology's Changing Landscape with Insights from Stephen McLeod

September 21st 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 22nd 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Study: Researchers find new mechanisms that cause blindness, opening the door to future treatments

September 22nd 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

September 13th 2023

Macular leakage is important in diabetic eye disease outcomes

September 21st 2023

Navigating Ophthalmology's Changing Landscape with Insights from Stephen McLeod

September 21st 2023

Foundation Fighting Blindness awards $900,000 to MitoChem Therapeutics to study target and mechanism of action in retinal degeneration disease

September 22nd 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Study: Researchers find new mechanisms that cause blindness, opening the door to future treatments

September 22nd 2023

Podcast: Modern approaches for the optimal treatment of dry eye disease (Part 4)

September 13th 2023

Macular leakage is important in diabetic eye disease outcomes

September 21st 2023

Navigating Ophthalmology's Changing Landscape with Insights from Stephen McLeod

September 21st 2023
© 2023 MJH Life Sciences

All rights reserved.